• Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

    المصدر: Buzz FX / 09 أكتوبر 2024 01:56:09   America/Chicago


    Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat October 9, 2024 Share Link copied to clipboard. Day One Biopharmaceuticals, Inc.
    Read more...
شارك على،